Studies in non-melanoma skin cancer (NMSC) have shown that increased LGALS7 mRNA and Gal-7 protein expression are associated with myeloid programs, elevated CXCL1 levels, and c-MET activation. This evidence concerns the gene MET and non-melanoma skin carcinoma.